VREX Stock Analysis: Buy, Sell, or Hold?
VREX - Varex Imaging Corporation Common Stock
$10.61
-0.07 (-0.66%)
▼
5d:
+3.11%
30d:
+6.74%
90d:
-0.09%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When VREX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: VREX appears deeply undervalued. Market expects -5.8% annual earnings decline despite 453% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: VREX appears deeply undervalued. Market expects -5.8% annual earnings decline despite 453% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$24.66
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$15.31
30.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VREX is currently trading at $10.61, which is considered slightly high relative to its 30-day fair value range of $10.13 to $10.67. From a valuation perspective, the stock is trading at a discount (Forward PE: 10.0) compared to its historical average (11.9). Remarkably, the market is currently pricing in an annual earnings decline of 5.8% over the next few years. This pessimistic expectation contrasts with the company's recent 453.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, VREX is in a strong downtrend. Immediate support is located at $9.59, while resistance sits at $10.99.
Market Sentiment: VREX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $18.00 (+69.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VREX is in a strong downtrend. Immediate support is located at $9.59, while resistance sits at $10.99.
Market Sentiment: VREX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $18.00 (+69.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$10.13 -
$10.67
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
76.2%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 69.7% below Wall St target ($18.00)
Trading Range Analysis
30-Day Trading Range
$10.13 -
$10.67
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$9.59
Resistance Level
$10.99
Current Trend
Strong Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.97
Wall Street Target
$18.00
(+69.7%)
Revenue Growth (YoY)
1.5%
Earnings Growth (YoY)
453.4%
Profit Margin
-9.6%
Valuation Discount vs History
-5.8% cheaper
PE vs Historical
10.0 vs 11.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.8%
(market-implied from PE analysis)
1-Year Target
$9.99
(-6%)
2-Year Target
$9.41
(-11%)
3-Year Target
$8.87
(-16%)
3-Yr Target (if PE normalizes)
(PE: 10→12)
$10.58
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 36.8%)
$59.28
(+459%)
Base:
(SPY PE: 10.0, Growth: 36.8%)
$27.14
(+156%)
Bear:
(PE: 8.5, Growth: 36.8%)
$23.07
(+117%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.0 to 11.9
Stabilization Target:
$12.66
(+19.3%)
PE Expansion Potential:
+19.3%
Share & Embed Analysis
Last updated: July 05, 2026 5:04 PM ET
Data refreshes hourly during market hours. Next update: 6:04 PM
Data refreshes hourly during market hours. Next update: 6:04 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VREX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Jay K Kunkel
SELL
4510 shares
2026-03-20
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 65 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 65 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$240 | 65 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 65 BUY |
